Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
a powerful Anti-Inflammatory pharmaceutical composition for use in established Allergic Contact Dermatitis More
Novel PIM 1 Kinase Inhibitor that Upregulates RUNX3 for the Treatment of Allergic Diseases More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2011 - 89 pages - $3,500
Dec 2010 - $15,200
Apr 2011 - 45 pages - $3,800
Jul 2011 - 96 pages - $3,835
Nov 2009 - 142 pages - $2,350
Feb 2011 - 92 pages - $500
Feb 2006 - 332 pages - $3,900
Oct 2011 - 68 pages - $3,500
Nov 2010 - 50 pages - $500
Mar 2011 - 19 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us